The primary outcome of endotracheal intubation or death within 7 days occurred in 39% in the high-flow nasal oxygen group vs 38% in the noninvasive ventilation group overall. Israel S. Maia, M.D., ...
M ONDAY, Dec. 16, 2024 (HealthDay News) -- High-flow nasal oxygen (HFNO) is noninferior to noninvasive ventilation (NIV) for endotracheal intubation or death within seven days for most patients ...
MONDAY, Dec. 16, 2024 (HealthDay News) -- High-flow nasal oxygen (HFNO) is noninferior to noninvasive ventilation (NIV) for endotracheal intubation or death within seven days for most patients with ...